Advanced search
Publication Cover
Leukemia & Lymphoma Volume 46, 2005 - Issue 2
Submit an article Journal homepage
102
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Interferon a and T-cell responses in chronic myeloid leukemia

Andreas Burchert Klinikum der Philipps Universität Marburg, Klinik für Hämatologie, Onkologie und Immunologie Marburg Germany
&
Andreas Neubauer Klinikum der Philipps Universität Marburg, Klinik für Hämatologie, Onkologie und Immunologie Marburg Germany
Pages 167-175 | Published online: 01 Jul 2009

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Vibe Skov, Caroline Hasselbalch Riley, Mads Thomassen, Lasse Kjær, Thomas Stauffer Larsen, Ole Weis Bjerrum, Torben A Kruse & Hans Carl Hasselbalch. (2017) The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms. Leukemia & Lymphoma 58:8, pages 1914-1921.
Read now
Vibe Skov, Caroline Hasselbalch Riley, Mads Thomassen, Thomas Stauffer Larsen, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse & Hans Carl Hasselbalch. (2013) Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis. Leukemia & Lymphoma 54:10, pages 2269-2273.
Read now
Michael Schmitt, Rosaely Casalegno-Garduño, Xun Xu & Anita Schmitt. (2009) Peptide vaccines for patients with acute myeloid leukemia. Expert Review of Vaccines 8:10, pages 1415-1425.
Read now

Articles from other publishers (25)

Inge G.P. Geelen, Stein-Erik Gullaksen, Mette M. Ilander, Ulla Olssen-Strömberg, Satu Mustjoki, Johan Richter, Nicole M.A. Blijlevens, Willem M. Smit, Bjorn T. Gjertsen, Tobias Gedde-Dahl, Berit Markevärn, Malika M.A. Koppes, Peter E. Westerweel, Henrik Hjorth-Hansen & Jeroen J.W.M. Janssen. (2023) Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects. Annals of Hematology 102:6, pages 1395-1408.
Crossref
Lucia Vráblová, Vladimír Divoký, Pavla Kořalková, Kateřina Machová Poláková, Eva Kriegová, Romana Janská, Jan Grohmann, Milena Holzerová, Tomáš Papajík & Edgar Faber. (2023) Deep Molecular Response Achieved with Chemotherapy, Dasatinib and Interferon α in Patients with Lymphoid Blast Crisis of Chronic Myeloid Leukaemia. International Journal of Molecular Sciences 24:3, pages 2050.
Crossref
Valentina R. Minciacchi, Rahul Kumar & Daniela S. Krause. (2021) Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future. Cells 10:1, pages 117.
Crossref
Sonjoy Pan, Soumyendu Raha & Siddhartha P. Chakrabarty. (2020) A quantitative study on the role of TKI combined with Wnt/β-catenin signaling and IFN-α in the treatment of CML through deterministic and stochastic approaches. Chaos, Solitons & Fractals 133, pages 109627.
Crossref
Svetlana Bunimovich-Mendrazitsky & Benzion Shklyar. (2017) Optimization of Combined Leukemia Therapy by Finite-Dimensional Optimal Control Modeling. Journal of Optimization Theory and Applications 175:1, pages 218-235.
Crossref
Jun Chen, Yang Liu, Qilin Sun, Beiqing Wang, Ningli Li & Xiangdong Chen. (2016) CYR61 suppresses growth of human malignant melanoma. Oncology Reports 36:5, pages 2697-2704.
Crossref
L. Berezansky, S. Bunimovich-Mendrazitsky & B. Shklyar. (2015) Stability and Controllability Issues in Mathematical Modeling of the Intensive Treatment of Leukemia. Journal of Optimization Theory and Applications 167:1, pages 326-341.
Crossref
Stephanie M. TortorellaAndrew HungTom C. Karagiannis. (2015) The Implication of Cancer Progenitor Cells and the Role of Epigenetics in the Development of Novel Therapeutic Strategies for Chronic Myeloid Leukemia. Antioxidants & Redox Signaling 22:16, pages 1425-1462.
Crossref
C Riether, C M Schürch & A F Ochsenbein. (2014) Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death & Differentiation 22:2, pages 187-198.
Crossref
Maria Julia Bevilaqua Felippe. 2014. Equine Infectious Diseases. Equine Infectious Diseases 584 597.e5 .
Edgar Faber, Adam Kuba, Jana Zapletalova, Martina Divoka, Peter Rohon, Milena Holzerova, Marie Jarosova & Karel Indrak. (2013) Interferon-alpha in chronic myeloid leukemia revisited: A long-term retrospective study in Central and Northern Moravia. Biomedical Papers 157:3, pages 248-256.
Crossref
Leonid Berezansky, Svetlana Bunimovich-Mendrazitsky & Alexander Domoshnitsky. (2012) A mathematical model with time-varying delays in the combined treatment of chronic myeloid leukemia. Advances in Difference Equations 2012:1.
Crossref
Edgar FaberAdam KubaJana ZapletalováMartina DivokáŠárka RožmanováPeter RohoňMilena HolzerováMarie JarošováKarel Indrák on Behalf of Cooperating Gro. (2012) Operational Cures After Interferon-Alpha in Patients with Chronic Myeloid Leukemia in Central and Northern Moravia. Journal of Interferon & Cytokine Research 32:5, pages 230-234.
Crossref
Izhar Hardan, Anfisa Stanevsky, Yuliya Volchek, Tali Tohami, Ninette Amariglio, Luba Trakhtenbrot, Maya Koren-Michowitz, Avichai Shimoni & Arnon Nagler. (2012) Treatment with Interferon alpha prior to discontinuation of Imatinib in patients with chronic myeloid leukemia. Cytokine 57:2, pages 290-293.
Crossref
Shayne Cox GadBalveen Kaur, Gregory B. Lesinski & Abhik Ray Chaudhary. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Jean-Jacques KiladjianRuben A. Mesa & Ronald Hoffman. (2011) The renaissance of interferon therapy for the treatment of myeloid malignancies. Blood 117:18, pages 4706-4715.
Crossref
A. Burchert & A. Neubauer. (2011) Chronische myeloische LeukämieChronic myeloid leukemia. Der Internist 52:3, pages 283-296.
Crossref
Meetu Agrawal, Ravin J. Garg, Hagop Kantarjian & Jorge Cortes. (2010) Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: What Is the “Best” Therapy?. Current Oncology Reports 12:5, pages 302-313.
Crossref
Shayne Cox GadBalveen Kaur, Gregory B. Lesinski & Abhik Ray Chaudhury. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Andreas BurchertMartin C. MüllerPhilippe KostrewaPhilipp ErbenTilman BostelSimone LieblerRüdiger HehlmannAndreas NeubauerAndreas Hochhaus. (2010) Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia. Journal of Clinical Oncology 28:8, pages 1429-1435.
Crossref
Lisa A. Kujawski & Moshe Talpaz. (2007) The role of interferon-alpha in the treatment of chronic myeloid leukemia. Cytokine & Growth Factor Reviews 18:5-6, pages 459-471.
Crossref
Hidenobu Takahashi, Tatsuo Furukawa, Toshio Yano, Naoko Sato, Jun Takizawa, Tori Kurasaki, Takashi Abe, Miwako Narita, Masayoshi Masuko, Satoru Koyama, Ken Toba, Masuhiro Takahashi & Yoshifusa Aizawa. (2007) Identification of an overexpressed gene, HSPA4L, the product of which can provoke prevalent humoral immune responses in leukemia patients. Experimental Hematology 35:7, pages 1091-1099.
Crossref
Maria Julia Bevilaqua Felippe Flaminio. 2007. Equine Infectious Diseases. Equine Infectious Diseases 592 605 .
Axel Hoos & Robert Peter Gale. 2007. Myeloproliferative Disorders. Myeloproliferative Disorders 185 200 .
Michelle HolkoBryan R.G. Williams. (2006) Functional Annotation of IFN- α -Stimulated Gene Expression Profiles from Sensitive and Resistant Renal Cell Carcinoma Cell Lines . Journal of Interferon & Cytokine Research 26:8, pages 534-547.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.